| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 9,100 | $30 | $291.2K |
| J3262 | Injection, tocilizumab, 1 mg | 44,880 | $10 | $224.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 55,800 | $1 | $223.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 15,400 | $10 | $169.4K |
| J0897 | Injection, denosumab, 1 mg | 8,520 | $20 | $153.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 980 | $100 | $98K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,300 | $30 | $59.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 390 | $110 | $43.9K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 630 | $70 | $42.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 520 | $70 | $35.1K |